Sign in
TerminatedPhase 2

Massage for Prostate Cancer-Related Fatigue (mPROSTATE)

Key facts

Who runs it
University of Utah
Where
Salt Lake City, United StatesSee the site
Trial code
Status
Terminated
Phase
Phase 2
People taking part
28 people enrolled
Started
17 Jun 2022
Ended
2 Aug 2025
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Swedish Massage Therapy (SMT)
  • Light Touch (LT) Control
  • Waitlist Control (WLC)
Record updated
13 July 2026
Why it stopped
Lack of Funding

Who can take part

Age
45 years and older
Sex
Men only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 20 criteriaShow less

Who can take part

  • Male subjects aged >= 45 years old
  • Histologically confirmed diagnosis of prostate cancer
  • Subjects must have completed radiation therapy >= 2 months, prior to registration
  • Subjects who have a score > 25 on the Brief Fatigue Inventory (BFI) at screening
  • Subjects who are fluent in speaking and reading English
  • Based on International Classification of Diseases (ICD)-10 proposed criteria, the patient must have a diagnosis of CRF with evidence from the history, physical exam, and laboratory findings that the fatigue is a consequence of cancer or cancer therapy and not primarily a consequence of any of the following:; Comorbid psychiatric disorders; Anemia (hemoglobin less than 10 g/dl); Hypothyroidism (thyroid stimulating hormone (TSH) greater than 4.6 micro-international units (uIU)/mL); Uncontrolled pain; Any medical or psychiatric condition or medication felt to be clinically contributing to fatigue based on the investigator's history, physical examination, and assessment. These medical circumstances may include:; The use of medications such as opioids, sedating anti-histamines, or neuroleptics; Medical problems associated with fatigue: chronic obstructive pulmonary disease, congestive heart failure, renal disease, hepatic dysfunction, uncontrolled autoimmune disease, neurological disorders such as multiple sclerosis or Parkinson's disease, and sleep apnea
  • Able to provide informed consent and willing to sign an approved consent form that conforms to federal and institutional guidelines

Who cannot take part

  • Current use of any medications or therapies listed as prohibited in Section 6.6.1
  • Treatment with corticosteroids or other immunosuppressants =< 6 months prior to registration, , unless the medication is necessary to support patient wellbeing and unlikely to negatively impact study aims, per PI judgement
  • Regular use of anti-inflammatory drugs including non-steroidal anti-inflammatory drugs and natural products thought to have anti-inflammatory properties, unless the medication is necessary to support patient wellbeing and unlikely to negatively impact study aims, per PI judgement
  • Change in prescribed dose of medications for anxiety or depression =< 4 weeks prior to registration
  • Change in fluoxetine dose within =< 8 weeks prior to registration
  • Other conditions or behaviors that, in the opinion of the treating investigator, may negatively impact study participation, including the following:; Illicit drug use; Shift work; Current dieting; Excessive regular use of alcohol (more than two 5-ounce glasses of wine or equivalents/day); Any instance of binge drinking (more than 7 drinks in a 24-hour period) =< 6 months prior to registration
  • Subjects meeting criteria for a current substance use diagnosis or current diagnoses of schizophrenia, depression, generalized anxiety disorder, bipolar disorder, dementia, delirium, or obsessive compulsive disorder (OCD)
  • Medical, psychiatric, cognitive, or other conditions that may compromise the subject's ability to understand the subject information, give informed consent, comply with the study protocol, or complete the study
  • Inability to lay prone comfortably for 25 minutes and inability to lay supine comfortably for 25 minutes, given the nature of the massage intervention
  • Body-mass index less than 18.5 (kg/m\^2)
  • Subjects who cannot comply with the protocol for any reason
  • Subjects who are actively suicidal or homicidal
  • Current and/or past use of massage for the treatment of fatigue

Where in United States

  • Huntsman Cancer Institute/University of UtahSalt Lake City, United States

About the trial

What the trial wants to find out

This phase II trial investigates the effect of massage in decreasing prostate cancer-related fatigue. Massage therapy has well known health benefits. This trial aims to find out if massage and touch therapies reduce fatigue due to cancer, and to learn if these therapies are better than traditional medicine or psychology for cancer related fatigue.

The 3 groups in the trial

  • Swedish Massage Therapy (SMT)Treatment being tested

    Patients receive SMT over 45 minutes once weekly for 6 weeks.

  • Light Touch (LT)Sham treatment, for comparison

    Patients receive LT over 45 minutes once weekly for 6 weeks.

    Treatment: Light Touch (LT) Control

  • Waitlist Control (WLC)Existing treatment, for comparison

    Patients will sit and relax for 45 minutes before completing study assessments at weeks 3 and 6.

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
13 July 2026